Cargando…
Prospective individual patient data meta‐analysis: Evaluating convalescent plasma for COVID‐19
As the world faced the devastation of the COVID‐19 pandemic in late 2019 and early 2020, numerous clinical trials were initiated in many locations in an effort to establish the efficacy (or lack thereof) of potential treatments. As the pandemic has been shifting locations rapidly, individual studies...
Autores principales: | Goldfeld, Keith S., Wu, Danni, Tarpey, Thaddeus, Liu, Mengling, Wu, Yinxiang, Troxel, Andrea B., Petkova, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441650/ https://www.ncbi.nlm.nih.gov/pubmed/34164838 http://dx.doi.org/10.1002/sim.9115 |
Ejemplares similares
-
Developing a Bayesian hierarchical model for a prospective individual patient data meta-analysis with continuous monitoring
por: Wu, Danni, et al.
Publicado: (2023) -
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis
por: Troxel, Andrea B., et al.
Publicado: (2022) -
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
por: Park, Hyung, et al.
Publicado: (2022) -
Bayesian Index Models for Heterogeneous Treatment Effects on a Binary Outcome
por: Park, Hyung G., et al.
Publicado: (2023) -
Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
por: Millat-Martinez, Pere, et al.
Publicado: (2022)